SCHEMBL903372

SCHEMBL903372

C=C(/C=C\c1ccccc1C)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ KDM4E B2RXH2 3/20 0.39
▸ APOBEC3A P31941 1/20 0.39
▸ APOBEC3G Q9HC16 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ PABPC1 P11940 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CYP1A2 P05177 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ THPO P40225 1/20 0.36
▸ HIF1A Q16665 1/20 0.36
▸ NR1H2 P55055 1/20 0.36
▸ NR1H3 Q13133 1/20 0.36
▸ PTGER1 P34995 1/20 0.35
▸ PTGER4 P35408 1/20 0.35
▸ PTGER3 P43115 1/20 0.35
▸ PTGER2 P43116 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349679 0.85 RAB9A (0.41) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL26539118 0.81 ALDH1A1 (0.43) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL2961735 0.79 TSHR (0.45) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL8859640 0.79 ALDH1A1 (0.45) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL8349013 0.79 TSHR (0.45) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL17682919 0.77 TSHR (0.43) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL13816225 0.77 TSHR (0.43) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL19143585 0.76 RAB9A (0.36) RAB9AALDH1A1TSHRKDM4EAPOBEC3A
SCHEMBL22461004 0.76 RAB9A (0.44) RAB9AALDH1A1KDM4EMEN1KMT2A
SCHEMBL20373431 0.76 TSHR (0.42) RAB9AALDH1A1TSHRKDM4EAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013025490-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES CERULEAN PHARMA INC. (US) 2013-02-21 — — WO disclosed
WO-2012044832-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS FETZER OLIVER S (US) 2012-04-05 — — WO disclosed
WO-2011146638-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES CERULEAN PHARMA INC. (US) 2011-11-24 — — WO disclosed
WO-2011090940-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. (US) 2011-07-28 — — WO disclosed
Send feedback